Ipsen to relocate its North American headquarters to Massachusetts

Ipsen revealed plans to establish its North American headquarters in Cambridge, Massachusetts, with the company expecting to add about 250 jobs over the next few years to the site. Ispen noted that this will be its third global headquarters, alongside sites in the UK and France. 

"We are entering into a new era of innovation and growth for Ipsen as a leading global biotech company," remarked CEO Richard Paulson, adding "by bringing our headquarters to Cambridge, we will build a sustainable innovation engine to advance opportunities for our employees and our overall business."

FirstWord Reports: Providing insight, analysis and expert opinion on important Pharma trends and challenging issues <Click here>

Ipsen, which currently employs 150 staff in Cambridge, said it will co-locate its North America business with the company's Global External Innovation and Partnering, R&D and Manufacturing teams, along with certain global commercial roles, "creating a fully integrated biopharmaceutical business in the US."

Ipsen indicated that its current US headquarters based in Basking Ridge, New Jersey will transition to Cambridge over the next 12 months, while the company will maintain a core services centre in Basking Ridge. The drugmaker previously expanded its operations in Cambridge after gaining rights to the cancer drug Onivyde (irinotecan liposome injection) from Merrimack Pharmaceuticals last year.

To read more Top Story articles, click here.